TB500 peptide and injectable GHK-CU formulations are prohibited for compounding under current FDA regulations due to identified safety risks and insufficient human safety data
On July 23-24, 2026, the PCAC voted to recommend BPC-157, KPV, MOTS-c,TB-500, Epitalon and Semax for inclusion on the 503A Bulks List
Wall, ., Food and Nutrition Guidelines for Healthy Adolescents
Its used for managing type 2 diabetes and for chronic weight management
Is MOTS-C safe for long-term use
You could run into issues like: Compliance violations Patient safety problems Malpractice insurance coverage gaps Reputation damage Marketing and advertising claims risk Using restricted substances can even threaten your malpractice coverage